期刊文献+

骨髓增生异常综合征中CD34^+细胞CXCR4的表达及其与细胞迁移的相关性 被引量:2

CXCR4 expression of bone marrow CD34^+ cells in myelodysplastic syndromes and its correlation with cell migration
下载PDF
导出
摘要 目的:探讨不同危险度骨髓增生异常综合征(myelodysplasticsymdromes,MDS)中骨髓CD34+细胞CXCR4的表达情况及其与细胞迁移率的相关性。方法:收集40例骨髓增生异常综合征患者的骨髓标本,根据IPSS积分系统进行危险度分组。低危组20例:IPSS积分0~1.5分;高危组20例:IPSS积分≥1.5分;同时采集10例健康者的骨髓标本作为对照。分离纯化骨髓CD34+细胞,通过流式细胞术检测CXCR4膜蛋白的表达;研究SDF-1α趋化作用下CD34+细胞的迁移率及CD34+细胞对骨髓基质细胞的迁移率。结果:高危组MDS患者CD34+细胞CXCR4的表达率明显高于低危组和正常对照组(P<0.000 1);低危组和正常对照组之间CXCR4的表达率无显著性差异(P>0.05)。高危组CD34+细胞对SDF-1α及骨髓基质细胞的迁移率显著高于低危组及正常组(均P<0.000 1),且其对骨髓基质细胞的迁移率与CXCR4的表达呈正相关(P=0.000 1)。结论:高危组MDS患者CD34+细胞CXCR4的表达量及其对骨髓基质细胞的迁移率均明显高于低危组患者,且其迁移率随CXCR4表达量的增加而升高,不同风险组的MDS患者存在SDF-1及其受体CXCR4表达和功能上的差异,SDF-1及其受体CXCR4在MDS发病中具有重要作用。 Objective: To evaluate the expression of CXCR4 and the migration rate of bone marrow stromal CD34 cells in different risk groups with myelodysplastic syndromes (MDS) using correlation analysis. Methods: Forty MDS patients were divided into low- and high-risk groups based on the International Prognosis Scoring System (IPSS). The former was composed of 20 patients with IPSS〈1.5, whereas the latter was composed of 20 patients with IPSS 〉 1.5. Bone marrow (BM) samples of these patients and 10 normal controls were collected. CD34 cells were separated and purified. The expression of CXCR4 was determined by flow cytometry. The migration rate of CD34 cells on the chemotactic effect of SDF-1 and on the effect of bone marrow stromal cells were measured. Results: The expression rate of CXCR4 was higher in the high-risk MDS group than in the low-risk and control groups (P〈0.000 1). No significant differences existed between the low-risk and the control groups (〉0.05). The migration rate of CD34+ cells on the ef fects of SDF-1 a and marrow stromal cells were significantly increased in the high-risk MDS group compared with those in the low-risk and control groups (P〈0.000 1). Migration rate of CD34 cells on the effect of marrow stromal cells was positively correlated with CX- CR4 expression (P=0.000 1). Conclusion: The CXCR4 expression and migration rates of CD34+ cells on the effect of marrow stromal cells are significantly higher in the high-risk MDS group than in the low-risk group. Migration rate has a positive correlation with the CXCR4 expression, which further indicates that MDS is a heterogeneous group of hematopoietic stem cell malignancies. The expres- sion and function of SDF-1 and its receptor CXCR4 differ within each group with various risks. SDF-1 and CXCR4 may be involved inMDS pathogenesis.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2013年第18期1081-1084,共4页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金面上项目(编号:81270603) 天津市应用基础与前沿技术研究计划(编号:13JCYBJC22800)资助~~
关键词 骨髓增生异常综合征CXCR4 SDF-1 骨髓基质细胞迁移 myelodysplastic syndrome, CXCR4, SDF-1, marrow stromal cell, migration
  • 相关文献

参考文献13

  • 1Czader M, Orazi A. World Health Organization classification of myelodysplasticsyndromes[J]. Curt Pharm Des, 2012, 18(22): 3149-3162.
  • 2Tormo M, Marugtn I, Calabuig M. Myelodysplastic syndromes: an update on molecular pathology[J]. Clin Transl Oncol, 2010, 12 (10) :652-661.
  • 3Cheng M, Qin G. Progenitor cell mobilization and recruitment: SDF-1, CXCR4, a 4-integrin, and c-kit[J]. Prog Biology Transl Sci, 2012, 111:243-264.
  • 4Teicher BA, Fricker SP. CXCL12 (SDF-1)/CXCR4 pathway in cancer[J]. Clin Cancer Res, 2010, 16(11): 2927-2931.
  • 5Nervi B, Ramirez P, Rettig MP, et al. Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 an- tagonist AMD3100[J]. Blood, 2009, 113(24):6206-6214.
  • 6Vianello F, Villanova F, Tisato V, et al. Bone marrow mesenchy- mal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis[J]. Haematologica, 2010, 95(7):1081-1089.
  • 7Tauro S, Hepburn MD, Peddie CM, et al. Functional disturbance of marrow stromal microenvironment in the myelodysplastic syn- dromes[J]. Leukemia, 2002, 16(5):785-790.
  • 8Tauro S, Hepburn MD, Bowen DT, et al. Assessment of stromal function, and its potential contribution to deregulation of hemato- poiesis in the myelodysplastic syndromes[J]. Haematologica, 2001, 86(10):1038-1045.
  • 9Kastrinaki MC, Pontikoglou C, Klaus M, et al. Biologic characteris- tics of bone marrow mesenchymal stem cells in myelodysplastic syn- dromes[J]. Curr Stem Cell Res Ther, 2011, 6(2):122-130.
  • 10Varga G, Kiss J, VorkonyiJ, et al. Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of pa- tients with myelodysplastic syndromes[J]. Pathol Oncol Res, 2007, 13(4):311-319.

同被引文献39

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部